We are live on ! Find out more
COCH icon

Envoy Medical

33 hedge funds and large institutions have $11.5M invested in Envoy Medical in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,041% more capital invested

Capital invested by funds: $1.01M → $11.5M (+$10.5M)

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

22% more funds holding

Funds holding: 2733 (+6)

17.22% more ownership

Funds ownership: 5.27%22.49% (+17%)

Holders
33
Holders Change
+6
Holders Change %
+22.22%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
6
Reduced
2
Closed
6
Calls
Puts
Net Calls
Net Calls Change

COCH Hedge Fund Activity: Q1 2026 in Review

33 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2026, worth a combined $11.5M — up 1,041% from $1.01M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new COCH positions and 6 closed out — a net gain of 8 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $5.22M. The largest seller was Citadel Advisors, exiting entirely with an estimated $58.5K sold.

  • 33 institutional investors held Envoy Medical (COCH) as of Q1 2026, up from 27 in Q4 2025.
  • Funds reported $11.5M of Envoy Medical stock for Q1 2026, up 1,041% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q1 2026 and 6 closed out, a net change of +8 holders.
  • The largest Envoy Medical buyer in Q1 2026 was Nantahala Capital Management, an estimated $5.22M added.
  • The largest Envoy Medical seller in Q1 2026 was Citadel Advisors, an estimated $58.5K sold.

Based on aggregated 13F filings for Q1 2026.